DalsnaFinance

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

Stocks Zacks Investment Research By Zacks Investment Research 05 May 2026 07:00 1 min read
BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised  Zacks Investment Research

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised Zacks Investment Research

Read the full story on Zacks Investment Research → Opens the original article on news.google.com

Summary aggregated from Zacks Investment Research's public RSS feed. The full reporting belongs to Zacks Investment Research — please read it on their site.